The production of chemotactic cytokines in an allogeneic response. The role of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3.

The in vitro mixed lymphocyte reaction (MLR) is regarded as a model of responsiveness to allogeneic major histocompatibility complex antigens and has historically been used to elucidate the pathway of T lymphocyte proliferation. In addition, the MLR response may reflect activation pathways relevant in acute allograft rejection. In the present study, we have applied the MLR to examine the role of adhesion molecules intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3 in the induction of tumor necrosis factor-alpha (TNF-alpha) as well as chemotactic cytokines, interleukin-8 (IL-8), monocyte chemotactic protein-1 (MCP-1) and macrophage inflammatory protein-1 alpha (MIP-1 alpha). Monoclonal antibodies to the adhesion molecules (5 micrograms/ml) were added to one-way human MLR cultures and supernatants collected at various time points. The monoclonal antibodies to the adhesion molecules significantly suppressed the proliferative response by 50 to 80%. Cytokine production, TNF-alpha (3.2 +/- 0.5 ng/ml), MIP-1 alpha (12.9 +/- 3.3 ng/ml), MCP-1 (18.8 +/- 3.4 ng/ml), and IL-8 (57 +/- 18 ng/ml) peaked on day 5 of the assay. The addition of anti-intercellular adhesion molecule-1 to the cultures suppressed TNF-alpha, MIP-1 alpha, MCP-1, and IL-8 production by 68% (1.05 +/- 0.29 ng/ml), 85% (2.0 +/- 1.2 ng/ml), 63% (6.8 +/- 2.9 ng/ml), and 47% (30.3 +/- 3.7 ng/ml), respectively. Likewise, the addition of anti-lymphocyte function-associated antigen-3 monoclonal antibody suppressed the cytokines by 78% (0.71 +/- 0.34 ng/ml), 66% (4.5 +/- 2.2 ng/ml), 52% (8.8 +/- 2.2 ng/ml), and 73% (15.7 +/- 4.4 ng/ml), respectively. Immunohistochemical staining indicated that monocytes were the primary source of the chemokines IL-8, MCP-1, and MIP-1 alpha. The addition of exogenous recombinant TNF-alpha (5 ng/ml) or recombinant IL-2 (5 units/ml) to the anti-intercellular adhesion molecule-1-treated cultures allowed the recovery of the proliferative response as well as restoration of IL-2, TNF-alpha, and IL-8, but not MCP-1 or MIP-1 alpha, indicating that both soluble and adhesion molecule signals are required for the production of the C-C family of chemokines in allogeneic responses. Thus, the events resulting in cellular proliferation and chemokine production were dependent on adhesion molecule interactions.

[1]  Michael Loran Dustin,et al.  Regulation of locomotion and cell-cell contact area by the LFA-1 and ICAM-1 adhesion receptors. , 1992, Journal of immunology.

[2]  T. Fahey,et al.  Macrophage inflammatory protein 1 modulates macrophage function. , 1992, Journal of immunology.

[3]  P. Linsley,et al.  Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. , 1992, Journal of immunology.

[4]  S. Kanner,et al.  CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling. , 1992, Journal of immunology.

[5]  M. Isobe,et al.  Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. , 1992, Science.

[6]  D. S. Webb,et al.  Stimulation of human monocytes via CD45, CD44, and LFA-3 triggers macrophage-colony-stimulating factor production. Synergism with lipopolysaccharide and IL-1 beta. , 1992, Journal of immunology.

[7]  R. Rees,et al.  Evidence that interleukin-4 suppression of lymphokine-activated killer cell induction is mediated through monocytes. , 1992, Immunology.

[8]  M. Deckert,et al.  CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation. , 1992, Journal of immunology.

[9]  P. Kaye,et al.  Antigen presentation by dendritic cells provides optimal stimulation for the production of interleukin (IL) 2, IL 4 and interferon‐γ by allogeneic T cells , 1991, European journal of immunology.

[10]  R. Strieter,et al.  Human corneal interleukin-8. IL-1 and TNF-induced gene expression and secretion. , 1991, The American journal of pathology.

[11]  R. Greil,et al.  A monoclonal antibody directed against the human intercellular adhesion molecule (ICAM‐1) modulates the release of tumor necrosis factor‐α, interferon‐γ and interleukin 1 , 1990, European journal of immunology.

[12]  K. Okumura,et al.  Relative contribution of CD2 and LFA-1 to murine T and natural killer cell functions. , 1990, Journal of immunology.

[13]  T. Waldmann,et al.  Association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin 2 receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[15]  G. Canonica,et al.  Functional involvement of the LFA-1/ICAM-1 adhesion system in the autologous mixed lymphocyte reaction. , 1990, Cellular immunology.

[16]  R. Colvin,et al.  In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. , 1990, Journal of immunology.

[17]  J. Blay,et al.  Evidence for tumor necrosis factor-alpha involvement in the optimal induction of class I allospecific cytotoxic T cells. , 1990, Journal of immunology.

[18]  K. Horgan,et al.  The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. , 1990, Journal of immunology.

[19]  M. Hirokawa,et al.  Lymphokine activity production in graft-versus-host reactions across minor histocompatibility antigen barriers. , 1989, Clinical and experimental immunology.

[20]  R. Strieter,et al.  Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells. , 1989, Biochemical and biophysical research communications.

[21]  K. Matsushima,et al.  Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin 1 or tumor necrosis factor. , 1989, Biochemical and biophysical research communications.

[22]  R. Strieter,et al.  Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta. , 1989, Science.

[23]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[24]  R. Strieter,et al.  Interleukin-2-induced tumor necrosis factor-alpha (TNF-alpha) gene expression in human alveolar macrophages and blood monocytes. , 1989, The American review of respiratory disease.

[25]  T. Espevik,et al.  Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha , 1987, The Journal of experimental medicine.

[26]  P. Scheurich,et al.  Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses. , 1987, Journal of immunology.

[27]  M. Burdick,et al.  A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). , 1992, Immunological investigations.

[28]  E. Leonard,et al.  Human monocyte chemoattractant protein-1 (MCP-1). , 1991, Advances in experimental medicine and biology.

[29]  E. Leonard,et al.  Human monocyte chemoattractant protein-1 (MCP-1). , 1990, Immunology today.

[30]  R. Lechler,et al.  The molecular basis of alloreactivity. , 1990, Immunology today.

[31]  M. Vadas,et al.  Human interleukin 4 regulates the phenotype of lymphocytes generated during mixed lymphocyte culture and inhibits the IL-2-induced development of LAK function in normal and leukaemic cells. , 1989, Leukemia research.